SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ousters Rev8 lidar is drawing attention through integrations and planned deployments in Senecas autonomous wildfire drones, John Deeres orchard machines, and drone-mapping and infrastructure systems, reinforcing the communitys physical-AI growth thesis. Traders are split between optimism about customer traction and scaling production and concern over volatility, valuation, dilution, and execution.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase is under pressure alongside solar peers as traders cite rising Treasury yields and borrowing costs as headwinds for residential solar demand. The debate is split between bearish calls for further declines and dip buyers looking for a rebound, with some also pointing to the IQ SST data-center power opportunity as a longer-term potential catalyst.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

An unconfirmed report linking Innodata to Metas Muse AI agents has fueled trading interest, alongside discussion of growing demand for AI safety, evaluation and training services. Bulls see potential upside if the company benefits, while skeptics point to the lack of confirmation, possible share dilution and resistance after the sharp move.

Citigroup, Inc. is a holding company, which engages in the provision of financial products and services. It operates through the following segments: Services, Markets, Banking, Wealth, U.S. Personal Banking (USPB), and All Other. The Services segment includes Treasury and Trade Solutions (TTS) which provides an integrated suite of tailored cash management, trade, and working capital solutions to multinational corporations, financial institutions and public sector organizations, and Securities Services, which offers cross-border support for clients, providing on-the-ground local market expertise, post-trade technologies, customized data solutions, and a wide range of securities services solutions that can be tailored to meet client needs. The Markets segment provides corporate, institutional, and public sector clients around the world with a full range of sales and trading services across equities, foreign exchange, rates, spread products, and commodities. The Banking segment offers Investment Banking and Corporate Lending services. The Wealth segment includes Private Bank, Wealth at Work, and Citigold and provides financial services to a range of client segments through banking, lending, mortgages, investment, custody, and trust product offerings. The USPB segment includes Branded Cards and Retail Services, which have proprietary card portfolios and co-branded card portfolios within Branded Cards, and co-brand and private label relationships within Retail Services. The All Other segment consists of activities not assigned to the reportable operating segments, including certain unallocated costs of global functions, other corporate expenses, and net treasury results. The company was founded in 1812 and is headquartered in New York, NY.

Citigroup Inc

Citi is drawing attention ahead of bank earnings, as traders debate how higher yields and weakening economic conditions could affect lending, credit quality, and guidance. Some expect pressure on results and are bearish on bank stocks, while others view the pullback as a buying opportunity and point to bullish options activity.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Papua New Guinea, Australia, Ghana, Suriname, Argentina, Peru, Mexico, Canada, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmonts recent strength is drawing attention, with traders largely framing it as part of a bullish outlook for gold and miners amid inflation and currency-debasement concerns. Some speculate about a company-specific leak or an Alaska mining contract, but those theories are unconfirmed, and several traders say they have not identified a clear catalyst.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

ABVX is drawing attention as its share price continues to slide despite positive obefazimod ulcerative-colitis data, with traders debating whether a buyout will materialize or the company will need to wait for Crohns data and its planned NDA filing. Some see the pullback as an oversold buying opportunity, while others cite FDA safety uncertainty, broader biotech weakness and the risk of a long wait without a deal.

Bank of America Corp. is a bank and financial holding company, which engages in the provision of banking and nonbank financial services. It operates through the following segments: Consumer Banking, Global Wealth and Investment Management (GWIM), Global Banking, Global Markets, and All Other. The Consumer Banking segment offers credit, banking, and investment products and services to consumers and small businesses. The GWIM segment focuses on solutions to meet clients’ needs through a full set of investment management, brokerage, banking, and retirement products. The Global Banking segment deals with lending-related products and services, integrated working capital management and treasury solutions to clients, and underwriting and advisory services. The Global Markets segment includes sales and trading services, as well as research, to institutional clients across fixed-income, credit, currency, commodity, and equity businesses. The All Other segment consists of asset and liability management activities, equity investments, non-core mortgage loans and servicing activities, the net impact of periodic revisions to the mortgage servicing rights valuation model for both core and non-core MSRs, other liquidating businesses, residual expense allocations and other. The company was founded by Amadeo Peter Giannini in 1904 and is headquartered in Charlotte, NC.

Bank Of America Corp.

Bank of America Corp

Bank of Americas sharp pullback alongside other large banks ahead of quarterly results is driving discussion, with traders pointing to elevated Treasury yields, rate concerns and a softer capital-markets outlook. Some expect further downside, while others see the selloff as overdone and view the shares as oversold ahead of earnings.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Novartiss failed Phase 3 trial for a competing DM1 therapy has prompted concern that reducing DMPK may not translate into clinical benefit, weighing on Sarepta amid read-through selling. Traders disagree on how much that result applies to Sareptas differently delivered SRP-1003, with its upcoming DM1 data viewed as a key test and potential catalyst.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

SCHD is drawing attention as investors discuss a rotation between growth stocks and dividend-focused, defensive holdings, with many viewing the ETF as a steadier counterweight to tech volatility. Traders are split between buying dips for long-term income and questioning its recent pullbacks, which some attribute to rising Treasury yields making bonds more competitive.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Barclays downgrade of Joby, citing cash burn and doubts about manufacturing capacity, is driving the selloff and comparisons with its upgraded rival Archer. Traders disagree over whether the concerns are justified or the downgrade is a shakeout, with some buying the dip and others moving toward Archer.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lincoln Pharmaceuticals Ltd Targets Revenue of Rs. 1,000 Crore Within the Next Three Years

Ahmedabad (Gujarat) [India], November 14: Lincoln Pharmaceuticals Limited (BSE: 531633, NSE: LINCOLN), one of India's leading healthcare companies, has reported a consolidated net profit of Rs. 20.01 crore for the Q2 FY 2025-26. Total income for the quarter ended September 2025 was reported at Rs. 170.60 crore, and EBITDA was reported at Rs. 32.66 crore. Shareholders at the 31st Annual General Meeting (AGM) approved a dividend of Rs. 1.80 per share (18%) for the FY 2024-25.

Lincoln Pharmaceuticals targets 1000 crore revenues in next 3 years

During FY25, thecompany revenues grew by 5%year-on-year to 647 crore with states like Uttar Pradesh, Assam and Odisha making the maximumcontribution to the revenues from the domestic market

Lincoln Pharma posts Rs 11.62 cr profit for Jan-Mar; revenue rises to Rs 161 cr

Mumbai, May 22 (PTI) Lincoln Pharmaceuticals on Thursday reported a net … lifestyle and chronic segments. The pharma company had reported a net … strengthen our market presence,” Lincoln Pharmaceuticals Managing Director Mahendra Patel said …

Market Update: 450 Smallcap 10-41% ,

Market Trend: - , . . , 9.4% , 8%, 7%, 6%, 5.7% 5.2% . Smallcap 10-41% , - . 450 10% 41% , . , 25% . NGL Fine Chem 41.31% NGL Fine Chem , (Veterinary Active Pharmaceutical Ingredients) (APIs) . . , - . Natco Pharma 32.99% Natco Pharma , () . - . Excel Industries 32.79% Excel Industries (Agrochemicals & Specialty Chemicals) . , . Orchid Pharma 32.67% Orchid Pharma , (Cephalosporins) . (R&D) . WPIL 32.25% WPIL . , . Tilaknagar Industries 30.8% Tilaknagar Industries , IMFL (Indian Made Foreign Liquor) . , , . Banco Products (India) 30.58% Banco Products . , . Senco Gold 28.21% Senco Gold , , . . Suyog Telematics 28.15% Suyog Telematics . , . . Concord Biotech 27.71% Concord Biotech . , , . Zaggle Prepaid Ocean Services 26.82% Zaggle Prepaid (FinTech) SaaS (Software-as-a-Service) , Prince Pipes & Fittings 25.62% Prince Pipes & Fittings . , - . Gensol Engineering 25.57% Gensol Engineering (Solar Energy) , (Solar EPC) . , . Lincoln Pharmaceuticals 25.27% Lincoln Pharmaceuticals , . , -, . Suraj Estate Developers 25.

Lincoln Pharmaceuticals Ltd reports Standalone Net Profit of Rs. 20.77 crore in Q3 FY25

Ahmedabad (Gujarat) [India], February 13: Lincoln Pharmaceuticals Limited, one of India's leading healthcare companies, has reported a standalone net profit of Rs. 20.77 crore for the Q3 FY25 ended December 2024 as against a net profit of Rs. 28.04 crore in the corresponding period last year. Revenue from operations for the Q3 FY25 was reported at Rs. 146.55 crore over previous fiscal's same period revenue from operations of Rs. 146.45 crore. The company reported an EBITDA of Rs. 32.63 crore in Q3 FY25 as compared to Rs. 40.68 crore EBITDA in the corresponding period last year. EPS for Q3FY25 was at Rs. 10.37 per share.

Lincoln Pharmaceuticals Ltd. is a holding company, which engages in the manufacture and sale of pharmaceutical products. It focuses on different sectors such as cardiac, diabetic, anti-malarial, anti-biotic, anti-fungal, cephalosporin's, analgesic, and iron preparations. The company was founded in 1979 and is headquartered in Ahmedabad, India.

Current Price	558.10
Prev Close	566.00
Open	558.00
Dividend Yield	0.32%
50-Day Moving Average	602.53
Beta	0.09
Avg. Volume	33,903.29
PE Ratio	11.59

52-Week High	770.00
52-Week Low	440.00
Market Capitalization	11.23B
EPS (Annual)	43.88
Price to Book	1.48
Revenue Per Employee	4.9M

Feed

News

Sentiment

Fundamentals

Info

LINCOLN.NSE Fundamentals